Skip to main content
Premium Trial:

Request an Annual Quote

ABL, CRP-Santé Ink Software Licensing Agreement


Advanced Biological Laboratories has signed a commercial licensing agreement with the Public Research Center for Health (CRP-Santé), a Luxembourg-based biomedical research organization that allows it to include the latter's Context-based Modeling for Expeditious Typing (COMET) software, a tool for analyzing and classifying viral sequences, in its portfolio.

Chalom Sayada, CEO of ABL — which is also based in Luxembourg — said that his firm has already incorporated the software into DeepChek, its software for analyzing genomic data from HIV, hepatitis B virus, and HCV. "We are pleased …to have signed this exclusive commercial licensing agreement with CRP-Santé and to be able to promote COMET alone or embedded within ABL’s software applications," he said in a statement.

The financial terms of the agreement were not disclosed. COMET is still freely available for non-commercial research use.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.